To investigate the clinical significance of DLX4 isoforms in CML, we first performed ROC curve analysis to evaluate the ability of DLX4 expression to discriminate AML from controls. This evidence concerns the gene DLX4 and chronic myelogenous leukemia, BCR-ABL1 positive.